Vanda Pharmaceuticals Inc.

VNDA · Nasdaq · SIC 2834: Pharmaceutical Preparations
362
SEC Filings

Business Summary

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on developing and commercializing innovative therapies for high unmet medical needs. Its commercial products include Fanapt (iloperidone) for schizophrenia and bipolar I disorder, HETLIOZ (tasimelteon) for Non-24-Hour Sleep-Wake Disorder and Smith-Magenis syndrome, PONVORY (ponesimod) for relapsing forms of multiple sclerosis, and NEREUS (tradipitant) for prevention of vomiting induced by motion. The company also has pipeline candidates including Bysanti (milsaperidone) and imsidolimab.

Next Earnings

Q2 FY2026 — expected 2026-09-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVNDAdiscussed_in_filing Cybersecurity
topic_mentionVNDAdiscussed_in_filing Trusted Computing
topic_mentionVNDAdiscussed_in_filing Blockchain & Crypto
topic_mentionVNDAdiscussed_in_filing Supply Chain
topic_mentionVNDAdiscussed_in_filing Regulation
topic_mentionVNDAdiscussed_in_filing Healthcare & Bio
topic_mentionVNDAdiscussed_in_filing Sovereign & Government
topic_mentionVNDAdiscussed_in_filing Cybersecurity
topic_mentionVNDAdiscussed_in_filing Trusted Computing
topic_mentionVNDAdiscussed_in_filing Blockchain & Crypto
topic_mentionVNDAdiscussed_in_filing Supply Chain
topic_mentionVNDAdiscussed_in_filing Regulation
topic_mentionVNDAdiscussed_in_filing Healthcare & Bio
topic_mentionVNDAdiscussed_in_filing Sovereign & Government
topic_mentionVNDAdiscussed_in_filing Cybersecurity
topic_mentionVNDAdiscussed_in_filing Trusted Computing
topic_mentionVNDAdiscussed_in_filing Blockchain & Crypto
topic_mentionVNDAdiscussed_in_filing Supply Chain
topic_mentionVNDAdiscussed_in_filing Regulation
topic_mentionVNDAdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001628280-26-007460EDGAR88K words
2025-02-142024-12-310001628280-25-005761EDGAR—
2024-02-082023-12-310001628280-24-003785EDGAR—
2023-02-092022-12-310001628280-23-002857EDGAR—
2022-02-242021-12-310001628280-22-003629EDGAR—
2021-02-112020-12-310001347178-21-000005EDGAR—
2020-02-262019-12-310001347178-20-000003EDGAR—
2019-02-192018-12-310001347178-19-000003EDGAR—
2018-02-152017-12-310001193125-18-046425EDGAR—
2017-02-172016-12-310001193125-17-047317EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001628280-25-047317EDGAR26K words
2025-07-312025-06-300001628280-25-036861EDGAR—
2025-05-082025-03-310001628280-25-023448EDGAR—
2024-11-072024-09-300001628280-24-045970EDGAR—
2024-08-012024-06-300001628280-24-033866EDGAR—
2024-05-092024-03-310001628280-24-021952EDGAR—
2023-11-092023-09-300001628280-23-038029EDGAR—
2023-07-282023-06-300001628280-23-026000EDGAR—
2023-05-032023-03-310001628280-23-015267EDGAR—
2022-11-032022-09-300001628280-22-027951EDGAR—
2022-08-042022-06-300001628280-22-020848EDGAR—
2022-05-062022-03-310001628280-22-012834EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001628280-26-023222EDGAR1K words
2026-03-100001628280-26-016516EDGAR—
2026-02-230001628280-26-010376EDGAR—
2026-02-190001628280-26-009805EDGAR—
2026-02-110001628280-26-007256EDGAR—
2026-01-080001628280-26-001273EDGAR—
2025-12-310001628280-25-059155EDGAR—
2025-12-040001628280-25-055393EDGAR—
2025-11-280001628280-25-054225EDGAR—
2025-10-290001628280-25-047112EDGAR—

362 total filings indexed. 330 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

psychiatry-(schizophrenia,-bipolar-disorder,-major-depressive-disorder) sleep-disorders-(non-24-hour-sleep-wake-disorder,-smith-magenis-syndrome) neurology-(multiple-sclerosis) gastroenterology-(motion-sickness,-gastroparesis) dermatology-(generalized-pustular-psoriasis)

Company Identity

CIK0001347178
TickerVNDA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 523295f5844c3370bc1b0d2c9d009214dd717514bfaa087088373a9fc83a854b
parent: 933db653b9840052feaad6df8cffe1cfc719089cf37ed0d0891969fa0fe711bd
content hash: edfd6f03c094e94e16598e04f1a07120726a10f3b5ff38b178a9c37308a0bab7
signed: 2026-04-13T04:48:06.919Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf